Injective (INJ) is currently priced at $4.50, reflecting a 24-hour decline of 1.35%. The daily trading range has been narrow, with a high of $4.59 and a low of $4.45, indicating low volatility in recent trading.

The trading volume stands at 28,931,041, translating to a volume-to-market cap ratio of 6.42%, which suggests moderate trading activity relative to its market capitalization. Technical indicators show a downward trend in the short term, with the hourly moving averages reflecting declines across various periods, especially the 144 SMA at $4.63, down 2.73%.

Momentum indicators are also bearish, as evidenced by the 1-hour RSI at 39, indicating potential oversold conditions, while the 7-day RSI at 48 shows the asset is approaching neutral territory but still lacks bullish momentum. Over the past week, INJ has experienced a significant price decrease of approximately 13.69%, and the 14-day change is even steeper at around 14.80%.

The asset's performance over the past 30 days has shown a minor decline of 3.55%, highlighting a longer-term bearish sentiment. The all-time high for INJ remains significantly higher at $52.62, achieved in March 2024, indicating substantial room for price recovery if market conditions improve.

Given the current technical indicators, recent price performance, and overall market sentiment, the recommendation for Injective (INJ) is a Hold. While the asset is trading at a significant discount from its all-time high, the bearish trends in both price action and momentum suggest caution is warranted before initiating new positions.